98%
921
2 minutes
20
Aim: To overcome the clinical limitations of melittin, a potent anticancer host defense peptide, by developing a multifunctional, virus-like particle (VLP)-based delivery system that enhances tumor targeting, immune activation, and therapeutic safety.
Methods: A nanoplatform based on hepatitis B core virus-like particles (HBc VLPs) was engineered to encapsulate melittin. The design incorporated RGD peptides for improved tumor specificity, Tuftsin to promote phagocytosis, and M2pep to selectively target immunosuppressive M2 macrophages. An MMP-2-cleavable linker enabled tumor-specific activation, allowing controlled release of RGD-melittin and immune-stimulating peptides. Antitumor efficacy was evaluated in subcutaneous melanoma and lung metastasis mouse models.
Results: The multifunctional HBc VLP platform effectively protected melittin from enzymatic degradation, reduced off-target cytotoxicity, and improved tumor selectivity. It demonstrated significant tumor suppression and immune modulation in both melanoma and lung metastasis models, outperforming free melittin treatment.
Conclusion: This study presents a versatile, multifunctional VLP-based nanoplatform for the safe and effective delivery of melittin, offering enhanced tumor targeting and immune activation. The findings support its potential for clinical translation as a novel cancer immunotherapy strategy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12239800 | PMC |
http://dx.doi.org/10.1080/17435889.2025.2528591 | DOI Listing |
Nanomedicine (Lond)
July 2025
Key Laboratory of Biomedical Engineering of Fujian Province University, Department of Biomaterials, College of Materials, Xiamen University, Xiamen, P. R. China.
Aim: To overcome the clinical limitations of melittin, a potent anticancer host defense peptide, by developing a multifunctional, virus-like particle (VLP)-based delivery system that enhances tumor targeting, immune activation, and therapeutic safety.
Methods: A nanoplatform based on hepatitis B core virus-like particles (HBc VLPs) was engineered to encapsulate melittin. The design incorporated RGD peptides for improved tumor specificity, Tuftsin to promote phagocytosis, and M2pep to selectively target immunosuppressive M2 macrophages.
Biomaterials
January 2026
Department of Orthopaedics, Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Shanghai Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, PR China. Electronic address:
The current post-surgery treatment of bone tumors with 3D-printed implants is facing the dilemma of difficulty in reducing the recurrence rate, which is closely related to the inability of the implants to reverse M2 polarization and the loss of tumor phagocytosis of macrophages caused by residual tumor cells. In this study, a multifunctional therapeutic implant activating local tumor-eating macrophages and promote bone regeneration in stages was developed by assembling a co-delivery system that enriched CSF-1R inhibitors within the internal porous structure and immobilizes anti-SIRPɑ on the surface based on boron-nitrogen coordination bonds onto an aldehyde-rich 3D printed calcium phosphate scaffold using dynamic covalent bonds. The phenylboric acid-modified mesoporous silica nanoparticle served as an efficient drug carrier for the enrichment of CSF-1R inhibitor and stable binding of antibodies while preserving their bioactivity.
View Article and Find Full Text PDFiScience
June 2025
Department of Chemical Engineering, Stanford University, Stanford, CA 94305, USA.
We describe a versatile, targeted delivery platform based on the Hepatitis B core protein virus-like particle (VLP). Multiple protein mutations were combined with cell-free protein synthesis and anaerobic processing to enable reliable production of nanoparticles (NPs) loaded with single or multiple cargoes (typically with concentration factors >10ˆ4) and functionalized with single or multiple surface adducts. Our design supports multiple functional requirements while also enabling flexible and reliable production.
View Article and Find Full Text PDFActa Pharm Sin B
April 2025
Department of Medicinal Chemistry, Key Laboratory of Chemical Biology, Ministry of Education, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, China.
Interfering hepatitis B virus (HBV) capsid assembly holds promise as a therapeutic approach for chronic hepatitis B (CHB). Novel anti-HBV agents are urgently needed to overcome drug resistance challenges, with targeted protein degradation (TPD) emerging as a hopeful strategy. Herein, we report the first degradation of HBV core protein (HBC), a multifunctional structural protein, using small-molecule degraders developed by hydrophobic tagging (HyT) technology.
View Article and Find Full Text PDFAnimals (Basel)
November 2024
Department of Veterinary and Biosciences, Faculty of Veterinary Medicine, Ghent University, 9820 Merelbeke, Belgium.
Platforms have been shown to be a suitable environmental enrichment for broiler chickens, accommodating their motivation to roost and rest at an elevated position. In order to increase the animal welfare benefits, we designed prototype elevated platforms with additional functionalities: a local cooling system, a sheltered area underneath the platform and collection trays underneath the platform that prevent manure from falling on the litter. This study assessed the effects of these multifunctional platforms during thermoneutral and heat stress conditions on two key determinants of their commercial uptake potential, namely production performance, carcass and meat quality.
View Article and Find Full Text PDF